Radiologic parameters of ankylosing spondylitis patients treated with anti-TNF-α versus nonsteroidal anti-inflammatory drugs and sulfasalazine

被引:0
作者
Seung Min Son
Sung Hoon Choi
Jong Ki Shin
Tae Sik Goh
Jung Sub Lee
机构
[1] Pusan National University School of Medicine,Department of Orthopaedic Surgery, Pusan National University Yangsan Hospital
[2] Pusan National University School of Medicine,Department of Orthopaedic Surgery, Medical Research Institute
来源
European Spine Journal | 2019年 / 28卷
关键词
Ankylosing spondylitis; Sagittal balance; Radiologic parameters; Anti-TNF-α; Lumbar lordosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:649 / 657
页数:8
相关论文
共 291 条
[31]  
Thomas CL(2005)Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept Ann Rheum Dis 64 1305-1767
[32]  
Debarge R(2011)Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial Ann Rheum Dis 70 590-1985
[33]  
Demey G(2010)Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register Rheumatology (Oxford) 49 563-2712
[34]  
Roussouly P(1998)Compensatory spinopelvic balance over the hip axis and better reliability in measuring lordosis to the pelvic radius on standing lateral radiographs of adult volunteers and patients Spine (Phila Pa 1976) 23 1750-403
[35]  
Inman RD(2005)How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured? Arthritis Rheum 52 1979-1394
[36]  
Davis JC(2015)A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis Arthritis Rheumatol 67 2702-undefined
[37]  
Heijde D(2010)Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs Clin Rheumatol 29 399-undefined
[38]  
Diekman L(2009)Treatment recommendations for psoriatic arthritis Ann Rheum Dis 68 1387-undefined
[39]  
Sieper J(undefined)undefined undefined undefined undefined-undefined
[40]  
Kim SI(undefined)undefined undefined undefined undefined-undefined